Notably, (R,R)-BD-AcAc2 improved experimental colitis, targeting the priming and activation of the NLRP3 inflammasome and its downstream signaling molecules, inhibiting pyroptosis and inducing autophagy [121]. Here, NLRP3 is linked to colitis.